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Building a rheumatology team for East Africa
A call for action!
The East Africa region comprising Burundi, Kenya,
Rwanda, Tanzania and Uganda has an estimated popula-
tion of 160 million [1], yet only has six rheumatologists.
The challenge to meet the needs of so many people is
therefore immense. Until recently, however, there was
little perceived need for investment in rheumatic and mus-
culoskeletal diseases (RMDs), and the specialty of
rheumatology was regarded as pointless, or esoteric at
best [2]. Two important reasons underpinned this situ-
ation. First, RMDs were thought to be so uncommon in
this region to be effectively irrelevant. Second, the burden
of infectious diseases, typified by malaria and HIV, was so
high that there was little space for anything else on the
agenda of governments or other agencies. Why worry
about diseases of the elderly, when life was short and
RMDs in young people merited case reports for novelty
value?
Today, although many things are different, the situation
remains almost the same. Pioneering work from two
rheumatologists in Nairobi, Kenya, has clearly demon-
strated that not only the spectrum, but also the severity
and prevalence of RMDs in East Africa, are very similar to
those in the West [3]. A shock for everyone! Also, the
changing lifestyle in the West, with increasing obesity, al-
cohol consumption and lack of physical activity [4], is
being mirrored in East Africa and is likely to have a further
impact on RMDs. Moreover, the Fit for Work survey
undertaken in six European countries reported that 40%
of patients with RMDs had impaired earnings, and over
65% were forced to retire because of their musculoskel-
etal condition [5]; a similar survey would yield startling
results if reproduced in East Africa, with a higher propor-
tion of manual workers, but lacking the safety-net benefits
systems of the West. The data are starting to accrue to
indicate that RMDs should now figure on the radar of East
African Governments for investment. As yet, though, it has
not.
Is this a lost cause, with generations of people destined
to suffer unnecessarily? No—far from it! A combined ap-
proach, targeting support for growing specialist expertise,
alongside raising awareness of RMD in the community, is
starting to bear fruit. Starting with the ILAR East
Africa initiative, mentoring for the one rheumatologist in
Nairobi has spread, with support from rheumatology
units in the UK, Canada and South Africa, to grow
the number of rheumatology consultants in Kenya to
the current six (plus one paediatric rheumatologist).
This still falls far short of the WHO recommendations of
at least one rheumatologist per 100 000 people.
However, rheumatology clinics now also run in
Mombasa and Eldoret—yet the Kenyatta National
Hospital remains the only public institution offering
rheumatology services. Such a growth in consultant
staff, together with a successful Masters’ course that in-
cludes rheumatic diseases in Nairobi, means trainees are
starting to see rheumatology as an attractive specialty,
and the pharmaceutical industry is waking up to a poten-
tial market for RMD drugs in East Africa. This growth has
led to the formation of the Kenyan ArthRheuma Society,
which held its second annual meeting in July 2016, at-
tended by several international speakers.
In parallel with developments in secondary care, the
need to educate primary care and community doctors
about RMDs is being addressed by raising the awareness
of undergraduates through a move to include these con-
ditions on the medical curriculum. In addition, trained
rheumatologists are now helping to deliver this teaching
in at least some medical schools. The medical curricula
are not only for medical students, but also for residents
and students of other relevant health professions; this
needs to be expanded to include rheumatology. Setting
up regional rheumatology leagues within the umbrella of
the ArthRheuma Society should help to deliver relevant
courses with clear curricular goals, including continuing
medical education.
Collaborations between rheumatology associations and
universities will help strengthen existing teaching, provide
core knowledge of the RMDs to all practitioners and en-
courage rheumatology as a specialty within that region. An
example is the UWEZO initiative, which comprises a team
of rheumatologists, doctors, patients and researchers from
the UK, Sweden and Kenya [6]. This programme was
initiated in 2012 with funding from the International
Rheumatology League and Cornwall Arthritis Trust and
aims to improve access to basic musculoskeletal health
care at the local level in communities across Kenya: a pro-
ject that could be a model for other countries.
However, these initiatives are only the tip of the iceberg,
and there remains a woeful lack of training opportunities
for those considering specialization as rheumatologists.
All the current rheumatologists had to travel abroad to
receive their training, with attendant financial constraints.
Developing hybrid programmes of local and international
training, as occurs in Kuwait and Saudi Arabia, may be
more feasible. What would be best, though, is training
provided by East African Specialists in East Africa. With
the recent increase in specialists in Kenya, this is now
starting to become achievable.
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Unfortunately, one crucial part of the jigsaw of RMD
care in East Africa remains totally absent: the utilization
of specialist nurses and allied health workers. Worldwide,
they have been shown to improve rheumatology services
through their ability to enhance safety and quality, coord-
inate care and deliver maximal cost-effectiveness to ser-
vices [7]. Much has been achieved in highlighting the true
burden of RMDs in East Africa, and in starting to grow the
workforce to address this, and this been possible due to
support from the international community, matching the
vision and dedication of the rheumatology pioneers of the
East Africa region.
Building true rheumatology services appropriate
for the needs of East Africa cannot happen by this
route alone. What is required is a recognition by
the National Governments of the East African
countries of the size, scope and, very importantly, eco-
nomic benefits of addressing this burden. With data
accruing about the scope of the problem, a small
base of trained African rheumatologists supported
by international experts—and with the support of newly
forming patient groups—the time is coming for making
a breakthrough. We throw down the gauntlet and ask
the governments to rise and accept this challenge—be-
cause the successful management of RMD is of benefit
to all.
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